Albert Labs has appointed Professor Robert Britton and Dr Ricardo Jorge Dinis-Oliveira to its scientific advisory board (SAB).
The licence will enable research that will give a deeper understanding of psychedelic mushrooms and their interaction with the human body.
One company is hoping to combine the altered state of the psychedelic experience with the unreal environment of virtual reality (VR) to improve anxiety.
BetterLife Pharma has announced its first set of positive data showing the anti-depressant effects of an LSD derivative – 2-bromo-LSD (TD-0148A).
The clinical trial is aiming to understand how psilocybin alters brain function in order to improve treatment options for mental illness.
Freya Masters is a recent graduate from the University of St Andrews where she studied biochemistry.
